Princeton Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,844
Closed -$585K 95
2022
Q2
$585K Sell
7,844
-32
-0.4% -$2.92K 0.23% 67
2022
Q1
$1.01M Sell
7,876
-136
-2% -$14.9K 0.31% 57
2021
Q4
$1.08M Buy
8,012
+1,032
+15% +$148K 0.31% 61
2021
Q3
$954K Buy
6,980
+1,504
+27% +$190K 0.3% 58
2021
Q2
$585K Buy
5,476
+1,380
+34% +$133K 0.18% 69
2021
Q1
$368K Buy
+4,096
New +$384K 0.12% 79

Other funds holding DXCM

Princeton Capital Management's DXCM Position: Q3 2022 in Review

Princeton Capital Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 7,844 shares — an estimated $585K sold.

Princeton Capital Management first reported a position in DXCM in Q1 2021 and held it in 6 quarters. The position peaked at $1.08M in Q4 2021. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Princeton Capital Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Princeton Capital Management sold 7,844 DexCom shares in Q3 2022, an estimated $585K.
  • Princeton Capital Management first reported a position in DexCom in Q1 2021 and held it in 6 quarters.
  • Princeton Capital Management's DexCom position peaked at $1.08M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Princeton Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.